GANNON STEVEN
SEC insider (Form 3/4/5 filer). CIK 0001643085. Director at Xenon Pharmaceuticals Inc. (XENE). 10 reported Form 4/5 transactions since Sep 2024; latest on Aug 11, 2026. Located in BURNABY.
Companies GANNON STEVEN has filed insider reports for
- Xenon Pharmaceuticals Inc. (XENE): Director
GANNON STEVEN
CIK: 0001643085
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Xenon Pharmaceuticals Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Aug 11, 2026XENE
Xenon Pharmaceuticals Inc.
SaleDirect10K shares at avg. $64.06$641K - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
1.6K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
10.5K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect2.6K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
Tax PaymentDirect1.4K shares at avg. $53.41$76K - May 12, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect3.5K shares at avg. $7.38$26K - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
17K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
2.6K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
SaleDirect3 shares at avg. $30.48$91.44 - May 14, 2025XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect5.1K shares at avg. $12.57$65K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 11, 2026 | XENE Xenon Pharmaceuticals Inc. | Sale | 10,000 | $64.06 | $640,550 | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 1,593 | - | - | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 10,507 | - | - | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 2,645 | - | $0 | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Tax Payment | 1,416 | $53.41 | $75,629 | Direct |
| May 12, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 3,500 | $7.38 | $25,830 | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 17,012 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 2,645 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Sale | 3 | $30.48 | $91 | Direct |
| May 14, 2025 | XENE Xenon Pharmaceuticals Inc. | Exercise | 5,144 | $12.57 | $64,660 | Direct |
1-10 of 10 transactions